Religious fasting is associated with headache. This has been documented as “First
of Ramadan Headache” and “Yom Kippur Headache.” Rofecoxib (Vioxx®; Merck) and etoricoxib,
both Cox-2 inhibitors with 17- and 22-h half-lives, respectively, have been shown
to be effective in preventing fasting headache when taken just before the 25-h Yom
Kippur fast. Rofecoxib is no longer available. We hypothesized that etoricoxib would
also be effective in preventing fasting headache during the dawn-to-dusk Ramadan fast.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2011 Published by Elsevier Inc.
